Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06598098 · ClinicalTrials.gov registry record · NA

MAMA Tot - Healthy Weight Parallel Study

A NA study of Pregnancy Related, sponsored by East Carolina University.

Recruiting
Registry status
NA
Development phase
268
Enrollment target
1
Study location

NCT06598098: Recruiting NA study of Pregnancy Related, sponsored by East Carolina University.

NCT06598098 is a NA study of Pregnancy Related that is actively recruiting participants, run by East Carolina University. The registered enrollment target is 268 participants, below the 1,960-participant average among 99 other Pregnancy Related trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06598098, a NA study of Pregnancy Related, is actively recruiting participants, sponsored by East Carolina University.

RECRUITING
Registry status
NA
Development phase
268 participants
Enrollment target
1
Study location

Study Summary

The overall objective of this proposal is to conduct a longitudinal prospective study of healthy pregnant women and their offspring to determine which antenatal maternal exercise mode(s) will have the greatest impact on maternal and infant cardiometabolic health. This information may lead to modified clinical practice recommendations that improve health in childhood and possibly beyond. This randomized controlled trial will recruit 268 healthy pregnant women randomized to an exercise intervention (aerobic exercise, resistance exercise, aerobic and resistance exercise) or to no exercise (usual care); their infants will be measured at 1, 6, and 12 months of age. This rigorous design will test our central hypothesis that aerobic and resistance exercise and resistance exercise training during pregnancy will, in healthy weight BMI (HW) women, improve maternal and offspring cardiometabolic outcomes to a greater extent than AE alone. We will test this hypothesis with two specific aims: Aim 1. Determine the influence of different exercise modes during HW pregnancy on infant cardiometabolic health and growth trajectories. Hypothesis: AE, RE, and AERE by HW pregnant women will improve offspring neuromotor and cardiometabolic measures at 1, 6, and 12 months postpartum (e.g. decreased % body fat, BMI z-score, heart rate, non-HDL, and C-Reactive Protein (CRP); increased insulin sensitivity) compared to infants of HW pregnant women that do not exercise; AERE and RE will have the greatest impact on improving infant measures. Aim 2. Determine the most effective exercise mode in HW pregnancy on improving maternal cardiometabolic health outcomes. Hypothesis: AE, RE, and AERE by HW pregnant women will improve both maternal cardiometabolic health measures (e.g. decreased BMI z-score, non-HDL, % body fat, HR, weight gain) across pregnancy (16 to 36 weeks gestation) and overall pregnancy outcomes (e.g. lower incidence of gestational diabetes, pre-eclampsia, hypertension during gestatio

Primary Outcome

non-HDL measures from venipuncture

Conditions Studied

Interventions

  • BEHAVIORAL Exercise Modes

Study Locations (1)

North Carolina

  • East Carolina University - Greenville

Trial Details

FieldValue
Enrollment Target 268 participants
Start Date 2021-10-18
Est. Completion 2027-08-30
Phase NA
East Carolina University

58 total trials

What NCT06598098 shows while recruiting

NCT06598098 is an interventional study that assigns participants to a tested intervention. The registered 268 participants enrollment target is mid-sized for trials with a published cap, below the 1,960-participant average among 99 other Pregnancy Related trials with a reported enrollment target (86% lower).

The record links to 1 condition, with Pregnancy Related appearing as the primary indexed condition, and to 1 intervention - of which Exercise Modes is the first listed.

NCT06598098 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT06598098 about?

NCT06598098 is a clinical study titled "MAMA Tot - Healthy Weight Parallel Study". The overall objective of this proposal is to conduct a longitudinal prospective study of healthy pregnant women and their offspring to determine which antenatal maternal exercise mode(s) will have the greatest impact on maternal and infant cardiometabolic health. This information may lead to modifie...

What is the current status of trial NCT06598098?

This trial is currently recruiting. It is a NA study. The enrollment target is 268 participants. The study started on 2021-10-18. Estimated completion is 2027-08-30.

What conditions does trial NCT06598098 study?

This clinical trial studies the following conditions: Pregnancy Related.

What interventions are being tested in trial NCT06598098?

The interventions under investigation include: Exercise Modes (BEHAVIORAL).

Who is sponsoring clinical trial NCT06598098?

This trial is sponsored by East Carolina University, which has 58 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06598098 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy Related

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06598098's enrollment target sits among peer trials

268 38th of 99 higher than 62 of 99 other Pregnancy Related trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pregnancy Related trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05000632 · 268 participants · NA

    Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families

  • NCT05797831 · 268 participants · Phase 2

    Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

  • NCT05997381 · 268 participants · NA

    BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears

  • NCT06233461 · 268 participants · Phase 2

    A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06598098, the US trial registry maintained by the National Library of Medicine. NCT06598098 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.